Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Search

Page Path
HOME > Search
4 "Hyun Deok Shin"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Articles
Endoscopy
Clinical comparison of low-volume agents (oral sulfate solution and sodium picosulfate with magnesium citrate) for bowel preparation: the EASE study
Jeeyeon Kim, Hyun Gun Kim, Kyeong Ok Kim, Hyung Wook Kim, Jongha Park, Jeong-Sik Byeon, Sung-Wook Hwang, Hyun Deok Shin, Jeong Eun Shin, Hyo-Joon Yang, Hyun Seok Lee, Yunho Jung, Young-Seok Cho, Young Eun Joo, Dae-Seong Myung, Kyu Chan Huh, Eu Mi Ahn
Intest Res 2019;17(3):413-418.   Published online April 8, 2019
DOI: https://doi.org/10.5217/ir.2018.00156
AbstractAbstract PDFPubReaderePub
Background/Aims
This study compared the efficacy, compliance, and safety of bowel preparation between sodium picosulfate with magnesium citrate (SPMC) and oral sulfate solution (OSS).
Methods
A prospective randomized multicenter study was performed. Split preparation methods were performed in both groups; the SPMC group, 2 sachets on the day before, and 1 sachet on the day of the procedure, the OSS group, half of the OSS with 1 L of water on both the day before and the day of the procedure. The adenoma detection rate (ADR), adequacy of bowel preparation using the Boston Bowel Preparation Scale (BBPS) score, patient satisfaction on a visual analog scale (VAS), and safety were compared between the 2 groups.
Results
This study analyzed 229 patients (121 in the SPMC group and 108 in the OSS group). ADR showed no differences between 2 groups (51.7% vs. 41.7%, P> 0.05). The mean total BBPS score (7.95 vs. 8.11, P> 0.05) and adequate bowel preparation rate (94.9% vs. 96.3%, P> 0.05) were similar between the 2 groups. The mean VAS score for taste (7.62 vs. 6.87, P=0.006) was significantly higher in the SPMC group than in the OSS group. There were no significant differences in any other safety variables between the 2 groups except nausea symptom (36.1% vs. 20.3%, P=0.008).
Conclusions
Bowel preparation for colonoscopy using low volume OSS and SPMC yielded similar ADRs and levels of efficacy. SPMC had higher levels of satisfaction for taste and feeling than did OSS.

Citations

Citations to this article as recorded by  
  • Comments on Oral Sulfate Solution Is as Effective as Polyethylene Glycol with Ascorbic Acid in a Split Method for Bowel Preparation in Patients with Inactive Ulcerative Colitis: A Randomized, Multicenter, and Single-Blind Clinical Trial
    Ji Eun Kim
    Gut and Liver.2024; 18(1): 192.     CrossRef
  • Oral Sulfate Solution Is as Effective as Polyethylene Glycol with Ascorbic Acid in a Split Method for Bowel Preparation in Patients with Inactive Ulcerative Colitis: A Randomized, Multicenter, and Single-Blind Clinical Trial
    Ji Min Lee, Kang-Moon Lee, Ho Suk Kang, Ja Seol Koo, Hyun Seok Lee, Seok-Hoo Jeong, Jung Ho Kim, Dae Bum Kim
    Gut and Liver.2023; 17(4): 591.     CrossRef
  • Quality indicators in colonoscopy: the chasm between ideal and reality
    Su Bee Park, Jae Myung Cha
    Clinical Endoscopy.2022; 55(3): 332.     CrossRef
  • Comparison of the efficacy and safety between oral sulfate tablet and polyethylene glycol for bowel preparation before colonoscopy according to age
    Jae Hyun Kim, Yong Eun Park, Tae Oh Kim, Jongha Park, Gyu Man Oh, Won Moon, Seun Ja Park
    Medicine.2022; 101(27): e29884.     CrossRef
  • Efficacy, safety and tolerability of oral sulphate tablet for bowel preparation in patients with inflammatory bowel disease: A multicentre randomized controlled study
    Kyeong Ok Kim, Eun Young Kim, Yoo Jin Lee, Hyun Seok Lee, Eun Soo Kim, Yun Jin Chung, Byung Ik Jang, Sung Kook Kim, Chang Heon Yang
    Journal of Crohn's and Colitis.2022; 16(11): 1706.     CrossRef
  • Comparison of Two Types of 1-L Polyethylene Glycol-ascorbic Acid as Colonoscopic Bowel Preparation: A Prospective Randomized Study
    Suh Hyun Choi, Won Eui Yoon, Seung Hyuk Kim, Hee Jun Myung, Seo Hyun Kim, Soon Oh So, Se Hun Kim, Hyun Mi Lee, Yeoun Jung Oh, Jeong Seop Moon, Tae Yeong Park, You Sun Kim
    The Korean Journal of Gastroenterology.2022; 80(2): 85.     CrossRef
  • Correlation between Surrogate Quality Indicators for Adenoma Detection Rate and Adenoma Miss Rate in Qualified Colonoscopy, CORE Study: KASID Multicenter Study
    Jae Hee Han, Hyun Gun Kim, Eu Mi Ahn, Suyeon Park, Seong Ran Jeon, Jae Myung Cha, Min Seob Kwak, Yunho Jung, Jeong Eun Shin, Hyun Deok Shin, Young-Seok Cho
    Gut and Liver.2022; 16(5): 716.     CrossRef
  • How to Choose the Optimal Bowel Preparation Regimen for Colonoscopy
    Ji Eun Na, Eun Ran Kim
    The Ewha Medical Journal.2021; 44(4): 122.     CrossRef
  • Optimal Laxatives for Oral Colonoscopy Bowel Preparation: from High-volume to Novel Low-volume Solutions
    Soo-Young Na, Won Moon
    The Korean Journal of Gastroenterology.2020; 75(2): 65.     CrossRef
  • No inferioridad entre dos agentes de bajo volumen (Picosulfato de Sodio/Citrato de Magnesio vs. Sulfato de Sodio/Potasio/Magnesio) en la preparación de colon para procedimientos diagnósticos: estudio observacional
    Erika D. Pérez-Riveros, Margarita Rey R., Belén Mendoza De Molano, Juan Carlos Robayo, Jaime Solano Mariño, Rafael García Duperly, Andrés Gómez, Renzo Pinto Carta, Gerardo Ardila, Jose De la Hoz-Valle, Fernando Sierra-Arango
    Revista Colombiana de Gastroenterología.2020; 35(4): 436.     CrossRef
  • 8,754 View
  • 260 Download
  • 9 Web of Science
  • 10 Crossref
Close layer
Inhibitory Effect of Metformin Therapy on the Incidence of Colorectal Advanced Adenomas in Patients With Diabetes
Yo Han Kim, Ran Noh, Sun Young Cho, Seong Jun Park, Soung Min Jeon, Hyun Deok Shin, Suk Bae Kim, Jeong Eun Shin
Intest Res 2015;13(2):145-152.   Published online April 27, 2015
DOI: https://doi.org/10.5217/ir.2015.13.2.145
AbstractAbstract PDFPubReader
<b>Background/Aims</b><br/>

Metformin use has been associated with decreased colorectal cancer risk and mortality among diabetic patients. Recent research suggests that metformin use may decrease the incidence of colorectal adenomas in diabetic patients with previous colorectal cancer. This study aimed to assess the clinical effect of metformin use on the development of colorectal adenomas in diabetic patients without previous colorectal cancer.

Methods

Among 604 consecutive diabetic patients who underwent colonoscopic surveillance after initial colonoscopy between January 2002 and June 2012, 240 patients without previous colorectal cancer were enrolled in this study and were divided in two groups: 151 patients receiving metformin and 89 patients not receiving metformin. Patient demographics and clinical characteristics as well as the colorectal adenoma incidence rate were retrospectively analyzed.

Results

The incidence rate of total colorectal adenomas was not different according to metformin use (P=0.349). However, the advanced adenoma incidence rate was significantly lower in the metformin group compared with the non-metformin group (relative risk [RR], 0.09; P=0.011). Metformin use was independently associated with a decreased incidence of advanced colorectal adenomas after adjustment for clinically relevant factors (RR, 0.072; P=0.016). In addition, the cumulative development rate of advanced adenomas during follow-up was significantly lower in the metformin group compared with the non-metformin group (P=0.007).

Conclusions

Metformin use in diabetic patients without previous colorectal cancer is associated with a lower risk of advanced colorectal adenomas.

Citations

Citations to this article as recorded by  
  • Metformin Use Is Inversely Associated with Prevalent, but Not Incident Colorectal Adenomas
    Anna Krigel, Snow Trinh T. Nguyen, Nawar Talukder, Ching-Ho Huang, Carlos Buitrago, Gabriel Karkenny, Benjamin Lebwohl, Julian A. Abrams, James L. Araujo
    Digestive Diseases and Sciences.2022; 67(10): 4886.     CrossRef
  • The Impact of Diabetes Mellitus on the Second Primary Malignancies in Colorectal Cancer Patients
    Jana Halamkova, Tomas Kazda, Lucie Pehalova, Roman Gonec, Sarka Kozakova, Lucia Bohovicova, Ondrej Slaby, Regina Demlova, Marek Svoboda, Igor Kiss
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Suppressive effects of metformin on colorectal adenoma incidence and malignant progression
    Min Deng, Siqin Lei, Dongdong Huang, Hui Wang, Shuli Xia, Enping Xu, Yihua Wu, Honghe Zhang
    Pathology - Research and Practice.2020; 216(2): 152775.     CrossRef
  • Metformin and colorectal cancer: a systematic review, meta-analysis and meta-regression
    Cheng-Ann Winston Ng, Amy Aimei Jiang, Emma Min Shuen Toh, Cheng Han Ng, Zhi Hao Ong, Siyu Peng, Hui Yu Tham, Raghav Sundar, Choon Seng Chong, Chin Meng Khoo
    International Journal of Colorectal Disease.2020; 35(8): 1501.     CrossRef
  • Cirrhosis and insulin resistance: current knowledge, pathophysiological mechanisms, complications and potential treatments
    Frédéric Clarembeau, Georgia Bale, Nicolas Lanthier
    Clinical Science.2020; 134(16): 2117.     CrossRef
  • Age at menarche and risk of colorectal adenoma
    Nam Hee Kim, Jung Ho Park, Dong Il Park, Chong Il Sohn, Kyuyong Choi, Yoon Suk Jung
    The Korean Journal of Internal Medicine.2019; 34(5): 998.     CrossRef
  • Diabetes Mellitus: a Clinical Condition Associated with Metabolic Syndrome and Colorectal Cancer Risk
    Vesna Brzacki, Aleksandar Nagorni, Manolis Kallistratos, Athanasios Manolis, Dragan Lovic
    Current Pharmacology Reports.2019; 5(4): 205.     CrossRef
  • Diabetes Mellitus and Colon Carcinogenesis: Expectation for Inhibition of Colon Carcinogenesis by Oral Hypoglycemic Drugs
    Junichi Kato, Yohei Shirakami, Masahito Shimizu
    Gastrointestinal Disorders.2019; 1(2): 273.     CrossRef
  • Metformin Is Associated With Reduced Odds for Colorectal Cancer Among Persons With Diabetes
    Joshua Demb, Armaan Yaseyyedi, Lin Liu, Ranier Bustamante, Ashley Earles, Pradipta Ghosh, J. Silvio Gutkind, Andrew J. Gawron, Tonya R. Kaltenbach, Maria Elena Martinez, Samir Gupta
    Clinical and Translational Gastroenterology.2019; 10(11): e00092.     CrossRef
  • Metformin in colorectal cancer: molecular mechanism, preclinical and clinical aspects
    Muhamad Noor Alfarizal Kamarudin, Md. Moklesur Rahman Sarker, Jin-Rong Zhou, Ishwar Parhar
    Journal of Experimental & Clinical Cancer Research.2019;[Epub]     CrossRef
  • Postoperative adjuvant chemotherapy is associated with a lower incidence of colorectal adenomas in patients with previous colorectal cancer
    Hee Seung Lee, Sung Bae Kim, Hyun Jung Lee, Soo Jung Park, Sung Pil Hong, Jae Hee Cheon, Won Ho Kim, Tae Il Kim
    Gastrointestinal Endoscopy.2018; 87(3): 688.     CrossRef
  • Metformin use and the risk of colorectal adenoma: A systematic review and meta‐analysis
    Yoon Suk Jung, Chan Hyuk Park, Chang Soo Eun, Dong Il Park, Dong Soo Han
    Journal of Gastroenterology and Hepatology.2017; 32(5): 957.     CrossRef
  • The effect of metformin on the recurrence of colorectal adenoma in diabetic patients with previous colorectal adenoma
    Min Seok Han, Hyun Jung Lee, Soo Jung Park, Sung Pil Hong, Jae Hee Cheon, Won Ho Kim, Tae Il Kim
    International Journal of Colorectal Disease.2017; 32(8): 1223.     CrossRef
  • Ursodeoxycholic acid inhibits the proliferation of colon cancer cells by regulating oxidative stress and cancer stem-like cell growth
    Eun-Kyung Kim, Jae Hee Cho, EuiJoo Kim, Yoon Jae Kim, Aamir Ahmad
    PLOS ONE.2017; 12(7): e0181183.     CrossRef
  • Serum CEA and CA 19-9 Levels are Associated with the Presence and Severity of Colorectal Neoplasia
    Nam Hee Kim, Mi Yeon Lee, Jung Ho Park, Dong Il Park, Chong Il Sohn, Kyuyong Choi, Yoon Suk Jung
    Yonsei Medical Journal.2017; 58(5): 918.     CrossRef
  • Synergistic Benefit of Statin and Metformin in Gastrointestinal Malignancies
    George K. Nimako, Zachary A. P. Wintrob, Dmitriy A. Sulik, Jennifer L. Donato, Alice C. Ceacareanu
    Journal of Pharmacy Practice.2017; 30(2): 185.     CrossRef
  • Risk Factors for False Fecal Immunochemical Test Results in Colorectal Cancer Screening
    Nam Hee Kim, Jung Ho Park, Dong Il Park, Chong Il Sohn, Kyuyong Choi, Yoon Suk Jung
    Journal of Clinical Gastroenterology.2017; 51(2): 151.     CrossRef
  • Parameters of Glucose and Lipid Metabolism Affect the Occurrence of Colorectal Adenomas Detected by Surveillance Colonoscopies
    Nam Hee Kim, Jung Yul Suh, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Kyuyong Choi, Yoon Suk Jung
    Yonsei Medical Journal.2017; 58(2): 347.     CrossRef
  • Are Hemorrhoids Associated with False-Positive Fecal Immunochemical Test Results?
    Nam Hee Kim, Jung Ho Park, Dong Il Park, Chong Il Sohn, Kyuyong Choi, Yoon Suk Jung
    Yonsei Medical Journal.2017; 58(1): 150.     CrossRef
  • Association Between Low Relative Muscle Mass and the Risk of Colorectal Neoplasms
    Yoon Suk Jung, Nam Hee Kim, Seungho Ryu, Jung Ho Park, Dong Il Park, Chong Il Sohn
    Journal of Clinical Gastroenterology.2017; 51(10): e83.     CrossRef
  • Metformin therapy and the risk of colorectal adenoma in patients with type 2 diabetes: A meta-analysis
    Yi-Chao Hou, Qiang Hu, Jiao Huang, Jing-Yuan Fang, Hua Xiong
    Oncotarget.2017; 8(5): 8843.     CrossRef
  • Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis
    Feifei Liu, Lijing Yan, Zhan Wang, Yuanan Lu, Yuanyuan Chu, Xiangyu Li, Yisi Liu, Dongsheng Rui, Shaofa Nie, Hao Xiang
    Oncotarget.2017; 8(9): 16017.     CrossRef
  • Kaffee senkt Rückfallrate bei Patienten mit Kolonkarzinom im Stadium III
    Michael Fink
    Info Onkologie.2016; 19(4): 24.     CrossRef
  • Oxidative stress and metabolic disorders: Pathogenesis and therapeutic strategies
    Vibha Rani, Gagan Deep, Rakesh K. Singh, Komaraiah Palle, Umesh C.S. Yadav
    Life Sciences.2016; 148: 183.     CrossRef
  • Weight Change and Obesity Are Associated with a Risk of Adenoma Recurrence
    Yoon Suk Jung, Jung Ho Park, Dong Il Park, Chong Il Sohn, Kyuyong Choi
    Digestive Diseases and Sciences.2016; 61(9): 2694.     CrossRef
  • 14,313 View
  • 35 Download
  • 26 Web of Science
  • 25 Crossref
Close layer
Case Reports
Polyp Clearance via Operative and Endoscopic Polypectomy in Patients With Peutz-Jeghers Syndrome After Multiple Small Bowel Resections
Do Hyun Lee, Hyun Deok Shin, Woo Hee Cho, Kyoung Hwang Shin, Sora Lee, Jeong Eun Shin, Hwan Namgung, Ji Eun Gwon
Intest Res 2014;12(4):320-327.   Published online October 27, 2014
DOI: https://doi.org/10.5217/ir.2014.12.4.320
AbstractAbstract PDFPubReaderePub

Peutz-Jeghers syndrome is an autosomal dominant inherited disease that manifests as a combination of mucocutaneous pigmentation and gastrointestinal hamartomatous polyps that usually cause intussusception and intestinal hemorrhage. We report the case of a 40-year-old male patient who was diagnosed 20 years ago and had previously undergone 3 intestinal resection surgeries. This time, with the use of combined operative and endoscopic polypectomy, more than 100 polyps were removed. This technique is useful for providing a "clean" small intestine that allows the patient a long interval between laparotomies and reduces the complications associated with multiple laparotomies and resections.

Citations

Citations to this article as recorded by  
  • Ischemic Polypectomy Through Detachable Snare and Rubber Band Ligation in Peutz–Jeghers Syndrome
    Justin Ryan L. Tan, Jonard T. Co
    ACG Case Reports Journal.2024; 11(2): e01272.     CrossRef
  • Peutz-Jeghers syndrome
    Ilja Tacheci, Marcela Kopacova, Jan Bures
    Current Opinion in Gastroenterology.2021; 37(3): 245.     CrossRef
  • 9,356 View
  • 51 Download
  • 2 Web of Science
  • 2 Crossref
Close layer
Primary Linitis Plastica of the Colon with Mucinous Adenocarcinoma in Young Woman
Ji Hyun Suh, Hyun Deok Shin, Jeong Eun Shin, Hwan Namgung
Intest Res 2011;9(1):61-65.   Published online April 30, 2011
DOI: https://doi.org/10.5217/ir.2011.9.1.61
AbstractAbstract PDF
Adenocarcinoma is the most common pathologic diagnosis, representing >95% of colorectal cancers; mucinous adenocarcinoma (MA) accounts for 10-15% and SRC accounts for 0.1-2.4% of colorectal cancers. MA is defined as a tumor with ≥50% mucin. Patients with MAs have a poor prognosis, a higher proportion of peritoneal metastases, and present at a more advanced stage of disease. Linitis plastica involving the colon and rectum is usually a metastatic lesion from gastric cancer and other organs, such as the prostate, gallbladder, and breast. Primary linitis plastica of the colon is very rare. We managed a case of colon cancer occurring in a 19-year-old female with a histologic diagnosis of mucinous adenocarcinoma and morphologic features of linitis plastica. Herein we report a rare case of primary linitis plastica of the colon with a review of the literature. (Intest Res 2011;9: 14-65)
  • 2,452 View
  • 19 Download
Close layer

Intest Res : Intestinal Research
Close layer
TOP